{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:17:28Z","timestamp":1788938248113,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":34,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030384739","type":"print"},{"value":"9783030384746","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-38474-6_8","type":"book-chapter","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:06:35Z","timestamp":1589393195000},"page":"145-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hormone Therapy Effects on the Uterus"],"prefix":"10.1007","author":[{"given":"Liane","family":"Deligdisch-Schor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"8_CR1","doi-asserted-by":"crossref","unstructured":"Kase NG. The normal ovary part II: how steroid hormones work. In: Deligdisch L, Kase N, Cohen CJ, editors. Altchek\u2019s diagnosis and management of ovarian disorders. 3rd ed: Cambridge University Press; 2013. p. 37\u201363.","DOI":"10.1017\/CBO9781139003254.003"},{"key":"8_CR2","first-page":"200","volume":"47","author":"HW Kelley","year":"1976","unstructured":"Kelley HW, Miles PA, Buster JE, Scragg W. Adenocarcinoma of the endometrium in women taking sequentially oral contraceptives. Obstet Gynecol. 1976;47:200\u20132.","journal-title":"Obstet Gynecol"},{"key":"8_CR3","first-page":"503","volume":"46","author":"SG Silverberg","year":"1975","unstructured":"Silverberg SG, Makovski EL. Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol. 1975;46:503\u20136.","journal-title":"Obstet Gynecol"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/modpathol.2008.19","volume":"21","author":"GL Mutter","year":"2008","unstructured":"Mutter GL, Bergeron C, Deligdisch L, Ferenczy A, Glant M, Merino M, Williams AR, Blithe DL. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol. 2008;21:591\u20138.","journal-title":"Mod Pathol"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mjafi.2015.11.010","volume":"72","author":"SK Kathpalia","year":"2016","unstructured":"Kathpalia SK, Kapoor K, Sharma A. Complications in pregnancies after in vitro fertilization and embryo transfer. Med J Armed Forces India. 2016;72:211\u20134.","journal-title":"Med J Armed Forces India"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/aji.12508","volume":"75","author":"VA Kushnir","year":"2016","unstructured":"Kushnir VA, Soloukis S, Sang-Moth-Vega MG, Albertini DF, Darmon SK, Deligdisch L, Barad DM, Gleicher N. Systemic inflammation and autoimmunity in women with chronic endometritis. Am J Reprod Immunol. 2016;75:672\u20137.","journal-title":"Am J Reprod Immunol"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/annonc\/mdq463","volume":"22","author":"L Minig","year":"2011","unstructured":"Minig L, Franchi D, Boveri S, Casadio C, Bocciolone L, Sideri M. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol. 2011;22:643\u20139.","journal-title":"Ann Oncol"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0015-0282(97)81394-5","volume":"67","author":"L Deligdisch","year":"1997","unstructured":"Deligdisch L, Hirschmann S, Altchek A. Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata. Fertil Steril. 1997;67:837\u201341.","journal-title":"Fertil Steril"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJMoa1103182","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez J, Tatarchuk TF, Bouchard P, et al. Ullipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366:409\u201320.","journal-title":"N Engl J Med"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0002-9378(16)39706-X","volume":"54","author":"SB Gusberg","year":"1974","unstructured":"Gusberg SB. Precursors of corpus carcinoma: estrogens and adenomatous hyperplasia. Am J Obstet Gynecol. 1974;54:905\u201327.","journal-title":"Am J Obstet Gynecol"},{"key":"8_CR11","volume-title":"The uterus","author":"R Kistner","year":"1973","unstructured":"Kistner R. Alterations associated with estrogen-and estrogen-progestin combinations. In: The uterus. Baltimore MD: The Williams and Wilkins Co.; 1973, Monograph No 14, Chapter 12."},{"key":"8_CR12","first-page":"314","volume-title":"Altchek\u2019s diagnosis and management of ovarian disorders","author":"NG Kase","year":"2013","unstructured":"Kase NG. A clinical approach to post-menopausal hormone therapy. In: Altchek\u2019s diagnosis and management of ovarian disorders; 2013. p. 314\u20137. Chapter 20: Menopause."},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288:321\u201333.","journal-title":"JAMA"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/GME.0000000000000921","volume":"24","author":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel","year":"2017","unstructured":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24:728\u201353.","journal-title":"Menopause"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000022128","volume":"46","author":"L Deligdisch","year":"2000","unstructured":"Deligdisch L, Kase NG, Bleiweiss IJ. Endometrial cancer in elderly women: a histologic and steroid receptor study. Gerontology. 2000;46:17\u201321.","journal-title":"Gerontology"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0140-6736(96)07365-5","volume":"349","author":"SA Bereford","year":"1997","unstructured":"Bereford SA, Weiss NS, Voigt LF, McKnight B. Risk of endometrial Cancer in relation to use of estrogen combined with cyclic progestogen therapy in post-menopausal women. Lancet. 1997;349:458\u201361.","journal-title":"Lancet"},{"key":"8_CR17","first-page":"543","volume":"33","author":"RJ Zaino","year":"2014","unstructured":"Zaino RJ, Brady WE, Todd W, Leslie K, Fischer EG, Horowitz NS, Mannel RS, Walker JL, Ivanovic M, Duska LR. Histologic effects of medroxyprogesterone acetate on endometrial adenocarcinoma: a Gynecologic Oncology Group study. Int Gynecol Oncol. 2014;33:543\u201353.","journal-title":"Int Gynecol Oncol"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/humupd\/dmu056","volume":"21","author":"B Patell","year":"2014","unstructured":"Patell B, Figueroa S, Thakore S, Dahoud W, Bedalwy M, Messiano S. Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Hum Reprod Update. 2014;21:155\u201373.","journal-title":"Hum Reprod Update"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","volume":"90","author":"TC Randall","year":"1997","unstructured":"Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol. 1997;90:434\u201340.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"8_CR20","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e2","volume":"28","author":"F Falcone","year":"2017","unstructured":"Falcone F, Laurelli G, Losito S, DiNapoli M, Granata V, Greggi S. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J Gynecol Oncol. 2017;28(1):e2. \nhttps:\/\/doi.org\/10.3802\/jgo.2017.28.e2\n\n.","journal-title":"J Gynecol Oncol"},{"key":"8_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-015-0136-7","volume":"14","author":"O Inoue","year":"2016","unstructured":"Inoue O, Hamatani T, Susumu N, Yamagami W, Ogawa S, Takemoto T, Hirasawa A, Banno K, Kuji N, Tanaka M, Aoki D. Factors affecting pregnancy in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Reprod Biol Endocrinol. 2016;14:2. \nhttps:\/\/doi.org\/10.1186\/s12958-015-0136-7\n\n.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"8_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/IGC.0000000000000629","volume":"26","author":"MD van Gent","year":"2016","unstructured":"van Gent MD, Nicolae Cristea AR, de Kroon CD, Osse EM, Kagie MJ, Trimbos JB, Hazelbag HM, Smit VT, Bosse T. Exploring morphologic and molecular aspects of endometrial cancer under progesterone treatment in the context of fertility preservation. Int J Gynecol Cancer. 2016;26(3):483\u201390. \nhttps:\/\/doi.org\/10.1097\/IGC.0000000000000629\n\n.","journal-title":"Int J Gynecol Cancer"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1309\/AJCPM2TSDDF1MHBZ","volume":"138","author":"MJ Mentrikovsky","year":"2012","unstructured":"Mentrikovsky MJ, Shah AA, Hanley KZ, Atkins KA. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy. Am J Clin Pathol. 2012;138:524\u201334.","journal-title":"Am J Clin Pathol"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00004347-199810000-00003","volume":"17","author":"C Schlesinger","year":"1998","unstructured":"Schlesinger C, Kamoi S, Ascher S, Kendell M, Lage JM, Silverberg SG. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol. 1998;17:302\u201311.","journal-title":"Int J Gynecol Pathol"},{"key":"8_CR25","first-page":"181","volume":"78","author":"L Deligdisch","year":"2000","unstructured":"Deligdisch L, Kalir T, Cohen CJ, De Latour M, Le Bouedec G, Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Pathol. 2000;78:181\u20136. Selected for Breast Diseases: A Yearbook Quarterly 2001, publ. Mosby Yearbook Inc.","journal-title":"Gynecol Pathol"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/annonc\/mdt399","volume":"25","author":"AS Dieudonne","year":"2014","unstructured":"Dieudonne AS, Lambrechts D, Smeets D, Belmans A, Wildiers H, Paridaens R, Hyonil C, Timmerman D, Christiaens MR, Vergote I, Neven P. The rs 1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in post-menopausal women on tamoxifen. Ann Oncol. 2014;25:90\u20135.","journal-title":"Ann Oncol"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","volume":"11","author":"U Magriples","year":"1993","unstructured":"Magriples U, Naftolin F, Schwartz PE, Carcangiu M. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients J. Clin Oncol. 1993;11:485\u201390.","journal-title":"Clin Oncol"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00004347-199607000-00006","volume":"15","author":"PB Clement","year":"1996","unstructured":"Clement PB, Oliva E, Young RH. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated lesions. Int J Gynecol Pathol. 1996;15:222\u20139.","journal-title":"Int J Gynecol Pathol"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/gyno.1995.0005","volume":"59","author":"DC Robinson","year":"1995","unstructured":"Robinson DC, Bloss JD, Schiano MA. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients. Gynecol Oncol. 1995;59:186\u201390.","journal-title":"Gynecol Oncol"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/07357907.2017.1309546","volume":"35","author":"R Hrstka","year":"2017","unstructured":"Hrstka R, Podhorec J, Nenutil R, Sommerova L, Obacz J, Durech M, Faktor J, Bouchal P, Skoupilova H, Vojtesek B. Tamoxifen-dependent induction of AGR2 is associated with increased aggressiveness of endometrial cancer cells. Cancer Investig. 2017;35:313\u201324.","journal-title":"Cancer Investig"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1933719113503408","volume":"21","author":"S Gizzo","year":"2014","unstructured":"Gizzo S, Gangi S, Bertocco A, Noventa M, Fagherazzi S, Ancona E, Saccardi C, Patrelli TS, D\u2019Antona D, Nardelli GB. Levonogestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits-systematic review of literature. Reprod Sci. 2014;21:423\u201331.","journal-title":"Reprod Sci"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1530\/ERC-13-0020","volume":"20","author":"C Saccardi","year":"2013","unstructured":"Saccardi C, Gizzo S, Patrelli TS, Ancona E, Anis O, Di Gangi S, Vacillotto A, D\u2019Antona D, Nardelli GN. Endometrial surveillance in tamoxifen users: role, timing and accuracy of hysteroscopic investigation: observational longitudinal cohort study. Endocr Relat Cancer. 2013;20:455\u201362.","journal-title":"Endocr Relat Cancer"},{"key":"8_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013976","volume":"98","author":"Y Lee","year":"2019","unstructured":"Lee Y, Park YR, Kim HR, Lee JW. Event-free survival following early endometrial events in breast cancer patients treated with anti-hormonal therapy. A nationwide claims data study. Medicine (Baltimore). 2019;98:e13976.","journal-title":"Medicine (Baltimore)"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/modpathol.3880050","volume":"13","author":"L Deligdisch","year":"2000","unstructured":"Deligdisch L. Hormonal pathology of the endometrium. Mod Pathol. 2000;13:285\u201394.","journal-title":"Mod Pathol"}],"container-title":["Advances in Experimental Medicine and Biology","Hormonal Pathology of the Uterus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-38474-6_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:15:08Z","timestamp":1589393708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-38474-6_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030384739","9783030384746"],"references-count":34,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-38474-6_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"14 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}